$ISPH Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in INSPIRE PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in INSPIRE PHARMACEUTICALS INC. Get notifications about new insider transactions in INSPIRE PHARMACEUTICALS INC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 22 2010 | ISPH | INSPIRE PHARMACEUT ... | STAAB THOMAS R II | CFO & Treasurer | Option Exercise | A | 6.08 | 22,000 | 133,760 | 22,000 | |
Mar 03 2010 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Sell | S | 6.10 | 124 | 756 | 56,257 | 56.4 K to 56.3 K (-0.22 %) |
Mar 03 2010 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Sell | S | 6.11 | 100 | 611 | 56,381 | 56.5 K to 56.4 K (-0.18 %) |
Mar 03 2010 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Sell | S | 6.13 | 576 | 3,531 | 56,481 | 57.1 K to 56.5 K (-1.01 %) |
Mar 03 2010 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Sell | S | 6.14 | 100 | 614 | 57,057 | 57.2 K to 57.1 K (-0.17 %) |
Mar 03 2010 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Sell | S | 6.15 | 604 | 3,715 | 57,157 | 57.8 K to 57.2 K (-1.05 %) |
Mar 03 2010 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Sell | S | 6.16 | 496 | 3,055 | 57,761 | 58.3 K to 57.8 K (-0.85 %) |
Mar 19 2010 | ISPH | INSPIRE PHARMACEUT ... | ADAMS ADRIAN | President and CEO | Grant | A | 0.00 | 650,000 | 0 | 650,000 | 0 to 650 K |
Mar 02 2010 | ISPH | INSPIRE PHARMACEUT ... | ABERCROMBIE GEORGE B | Director | Option Exercise | A | 0.00 | 1,592 | 0 | 1,592 | |
Mar 02 2010 | ISPH | INSPIRE PHARMACEUT ... | ABERCROMBIE GEORGE B | Director | Option Exercise | A | 0.00 | 12,739 | 0 | 12,739 | |
Mar 02 2010 | ISPH | INSPIRE PHARMACEUT ... | ABERCROMBIE GEORGE B | Director | Option Exercise | A | 6.28 | 2,371 | 14,890 | 2,371 | |
Mar 02 2010 | ISPH | INSPIRE PHARMACEUT ... | ABERCROMBIE GEORGE B | Director | Option Exercise | A | 6.28 | 18,970 | 119,132 | 18,970 | |
Feb 23 2010 | ISPH | INSPIRE PHARMACEUT ... | ADAMS ADRIAN | President and CEO | Option Exercise | A | 6.35 | 350,000 | 2,222,500 | 350,000 | |
Mar 02 2010 | ISPH | INSPIRE PHARMACEUT ... | ABERCROMBIE GEORGE B | Director | Option Exercise | A | 0.00 | 1,592 | 0 | 1,592 | |
Mar 02 2010 | ISPH | INSPIRE PHARMACEUT ... | ABERCROMBIE GEORGE B | Director | Option Exercise | A | 0.00 | 12,739 | 0 | 12,739 | |
Mar 02 2010 | ISPH | INSPIRE PHARMACEUT ... | ABERCROMBIE GEORGE B | Director | Option Exercise | A | 6.28 | 2,371 | 14,890 | 2,371 | |
Mar 02 2010 | ISPH | INSPIRE PHARMACEUT ... | ABERCROMBIE GEORGE B | Director | Option Exercise | A | 6.28 | 18,970 | 119,132 | 18,970 | |
Jan 05 2010 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Sell | S | 5.55 | 100 | 555 | 60,257 | 60.4 K to 60.3 K (-0.17 %) |
Jan 05 2010 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Sell | S | 5.58 | 94 | 525 | 60,357 | 60.5 K to 60.4 K (-0.16 %) |
Jan 05 2010 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Sell | S | 5.59 | 106 | 593 | 60,451 | 60.6 K to 60.5 K (-0.18 %) |
Jan 05 2010 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Sell | S | 5.60 | 200 | 1,120 | 60,557 | 60.8 K to 60.6 K (-0.33 %) |
Jan 05 2010 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Sell | S | 5.61 | 1,100 | 6,171 | 60,757 | 61.9 K to 60.8 K (-1.78 %) |
Jan 05 2010 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Sell | S | 5.62 | 400 | 2,248 | 61,857 | 62.3 K to 61.9 K (-0.64 %) |
Feb 02 2010 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Sell | S | 5.40 | 1,200 | 6,480 | 58,257 | 59.5 K to 58.3 K (-2.02 %) |
Feb 02 2010 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Sell | S | 5.41 | 455 | 2,462 | 59,457 | 59.9 K to 59.5 K (-0.76 %) |
Feb 02 2010 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Sell | S | 5.43 | 45 | 244 | 59,912 | 60 K to 59.9 K (-0.08 %) |
Feb 02 2010 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Sell | S | 5.44 | 100 | 544 | 59,957 | 60.1 K to 60 K (-0.17 %) |
Feb 02 2010 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Sell | S | 5.46 | 200 | 1,092 | 60,057 | 60.3 K to 60.1 K (-0.33 %) |
Dec 08 2009 | ISPH | INSPIRE PHARMACEUT ... | SHAFFER CHRISTY L | President & CEO | Sell | S | 6.00 | 3,500 | 21,000 | 356,497 | 360 K to 356.5 K (-0.97 %) |
Dec 08 2009 | ISPH | INSPIRE PHARMACEUT ... | SHAFFER CHRISTY L | President & CEO | Sell | S | 6.00 | 1,500 | 9,000 | 359,997 | 361.5 K to 360 K (-0.41 %) |
Dec 02 2009 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Sell | S | 5.63 | 100 | 563 | 62,257 | 62.4 K to 62.3 K (-0.16 %) |
Dec 02 2009 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Sell | S | 5.65 | 100 | 565 | 62,357 | 62.5 K to 62.4 K (-0.16 %) |
Dec 02 2009 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Sell | S | 5.66 | 200 | 1,132 | 62,457 | 62.7 K to 62.5 K (-0.32 %) |
Dec 02 2009 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Sell | S | 5.68 | 300 | 1,704 | 62,657 | 63 K to 62.7 K (-0.48 %) |
Dec 02 2009 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Sell | S | 5.69 | 200 | 1,138 | 62,957 | 63.2 K to 63 K (-0.32 %) |
Dec 02 2009 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Sell | S | 5.70 | 282 | 1,607 | 63,157 | 63.4 K to 63.2 K (-0.44 %) |
Dec 02 2009 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Sell | S | 5.71 | 200 | 1,142 | 63,439 | 63.6 K to 63.4 K (-0.31 %) |
Dec 02 2009 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Sell | S | 5.72 | 300 | 1,716 | 63,639 | 63.9 K to 63.6 K (-0.47 %) |
Dec 02 2009 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Sell | S | 5.73 | 100 | 573 | 63,939 | 64 K to 63.9 K (-0.16 %) |
Dec 02 2009 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Sell | S | 5.74 | 50 | 287 | 64,039 | 64.1 K to 64 K (-0.08 %) |
Dec 02 2009 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Sell | S | 5.76 | 168 | 968 | 64,089 | 64.3 K to 64.1 K (-0.26 %) |
Nov 13 2009 | ISPH | INSPIRE PHARMACEUT ... | SHAFFER CHRISTY L | President & CEO | Option Exercise | A | 5.10 | 29,500 | 150,450 | 29,500 | |
Nov 13 2009 | ISPH | INSPIRE PHARMACEUT ... | Brazzell Romulus K | EVP & Head, Ophthal ... | Option Exercise | A | 5.10 | 13,250 | 67,575 | 13,250 | |
Nov 13 2009 | ISPH | INSPIRE PHARMACEUT ... | SCHACHLE JOSEPH K | EVP, Chief Commerci ... | Option Exercise | A | 5.10 | 13,250 | 67,575 | 13,250 | |
Nov 13 2009 | ISPH | INSPIRE PHARMACEUT ... | Spagnardi Joseph M | Senior VP, GC & Sec ... | Option Exercise | A | 5.10 | 10,250 | 52,275 | 10,250 | |
Nov 13 2009 | ISPH | INSPIRE PHARMACEUT ... | STAAB THOMAS R II | CFO & Treasurer | Option Exercise | A | 5.10 | 13,250 | 67,575 | 13,250 | |
Nov 13 2009 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Option Exercise | A | 5.10 | 13,250 | 67,575 | 13,250 | |
Oct 01 2009 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Sell | S | 5.17 | 200 | 1,034 | 66,257 | 66.5 K to 66.3 K (-0.30 %) |
Oct 01 2009 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Sell | S | 5.19 | 400 | 2,076 | 66,457 | 66.9 K to 66.5 K (-0.60 %) |
Oct 01 2009 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Sell | S | 5.20 | 300 | 1,560 | 66,857 | 67.2 K to 66.9 K (-0.45 %) |
Oct 01 2009 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Sell | S | 5.21 | 1,100 | 5,731 | 67,157 | 68.3 K to 67.2 K (-1.61 %) |
Nov 03 2009 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Sell | S | 4.54 | 300 | 1,362 | 64,257 | 64.6 K to 64.3 K (-0.46 %) |
Nov 03 2009 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Sell | S | 4.55 | 600 | 2,730 | 64,557 | 65.2 K to 64.6 K (-0.92 %) |
Nov 03 2009 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Sell | S | 4.56 | 900 | 4,104 | 65,157 | 66.1 K to 65.2 K (-1.36 %) |
Nov 03 2009 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Sell | S | 4.58 | 200 | 916 | 66,057 | 66.3 K to 66.1 K (-0.30 %) |
Sep 01 2009 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Sell | S | 5.62 | 48 | 270 | 68,257 | 68.3 K to 68.3 K (-0.07 %) |
Sep 01 2009 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Sell | S | 5.67 | 1,000 | 5,670 | 68,305 | 69.3 K to 68.3 K (-1.44 %) |
Sep 01 2009 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Sell | S | 5.68 | 552 | 3,135 | 69,305 | 69.9 K to 69.3 K (-0.79 %) |
Sep 01 2009 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Sell | S | 5.69 | 100 | 569 | 69,857 | 70 K to 69.9 K (-0.14 %) |
Sep 01 2009 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Sell | S | 5.70 | 137 | 781 | 69,957 | 70.1 K to 70 K (-0.20 %) |
Sep 01 2009 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Sell | S | 5.71 | 100 | 571 | 70,094 | 70.2 K to 70.1 K (-0.14 %) |
Sep 01 2009 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Sell | S | 5.73 | 63 | 361 | 70,194 | 70.3 K to 70.2 K (-0.09 %) |
Aug 25 2009 | ISPH | INSPIRE PHARMACEUT ... | SHAFFER CHRISTY L | President & CEO | Sell | S | 6.01 | 3,700 | 22,237 | 361,497 | 365.2 K to 361.5 K (-1.01 %) |
Aug 25 2009 | ISPH | INSPIRE PHARMACEUT ... | SHAFFER CHRISTY L | President & CEO | Sell | S | 6.02 | 2,900 | 17,458 | 365,197 | 368.1 K to 365.2 K (-0.79 %) |
Aug 25 2009 | ISPH | INSPIRE PHARMACEUT ... | SHAFFER CHRISTY L | President & CEO | Sell | S | 6.03 | 1,200 | 7,236 | 368,097 | 369.3 K to 368.1 K (-0.32 %) |
Aug 25 2009 | ISPH | INSPIRE PHARMACEUT ... | SHAFFER CHRISTY L | President & CEO | Sell | S | 6.04 | 400 | 2,416 | 369,297 | 369.7 K to 369.3 K (-0.11 %) |
Aug 25 2009 | ISPH | INSPIRE PHARMACEUT ... | SHAFFER CHRISTY L | President & CEO | Sell | S | 6.05 | 1,800 | 10,890 | 369,697 | 371.5 K to 369.7 K (-0.48 %) |
Aug 13 2009 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Option Exercise | A | 4.55 | 13,250 | 60,288 | 13,250 | |
Aug 13 2009 | ISPH | INSPIRE PHARMACEUT ... | STAAB THOMAS R II | CFO & Treasurer | Option Exercise | A | 4.55 | 13,250 | 60,288 | 13,250 | |
Aug 13 2009 | ISPH | INSPIRE PHARMACEUT ... | Spagnardi Joseph M | Senior VP, GC & Sec ... | Option Exercise | A | 4.55 | 10,250 | 46,638 | 10,250 | |
Aug 13 2009 | ISPH | INSPIRE PHARMACEUT ... | SHAFFER CHRISTY L | President & CEO | Option Exercise | A | 4.55 | 29,500 | 134,225 | 29,500 | |
Aug 13 2009 | ISPH | INSPIRE PHARMACEUT ... | Brazzell Romulus K | EVP & Head, Ophthal ... | Option Exercise | A | 4.55 | 13,250 | 60,288 | 13,250 | |
Aug 13 2009 | ISPH | INSPIRE PHARMACEUT ... | SCHACHLE JOSEPH K | EVP, Chief Commerci ... | Option Exercise | A | 4.55 | 13,250 | 60,288 | 13,250 | |
Aug 10 2009 | ISPH | INSPIRE PHARMACEUT ... | Warburg Pincus Private Equity ... | 10% Owner | Buy | P | 4.50 | 8,888,888 | 39,999,996 | 22,907,488 | 14 M to 22.9 M (+63.41 %) |
Aug 10 2009 | ISPH | INSPIRE PHARMACEUT ... | LEFF JONATHAN S | Director | Buy | P | 4.50 | 8,888,888 | 39,999,996 | 22,907,488 | 14 M to 22.9 M (+63.41 %) |
Aug 03 2009 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Sell | S | 4.61 | 100 | 461 | 70,257 | 70.4 K to 70.3 K (-0.14 %) |
Aug 03 2009 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Sell | S | 4.68 | 100 | 468 | 70,357 | 70.5 K to 70.4 K (-0.14 %) |
Aug 03 2009 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Sell | S | 4.71 | 200 | 942 | 70,457 | 70.7 K to 70.5 K (-0.28 %) |
Aug 03 2009 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Sell | S | 4.72 | 300 | 1,416 | 70,657 | 71 K to 70.7 K (-0.42 %) |
Aug 03 2009 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Sell | S | 4.79 | 100 | 479 | 70,957 | 71.1 K to 71 K (-0.14 %) |
Aug 03 2009 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Sell | S | 4.82 | 478 | 2,304 | 71,057 | 71.5 K to 71.1 K (-0.67 %) |
Aug 03 2009 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Sell | S | 4.84 | 22 | 106 | 71,535 | 71.6 K to 71.5 K (-0.03 %) |
Aug 03 2009 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Sell | S | 4.88 | 200 | 976 | 71,557 | 71.8 K to 71.6 K (-0.28 %) |
Aug 03 2009 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Sell | S | 4.94 | 200 | 988 | 71,757 | 72 K to 71.8 K (-0.28 %) |
Aug 03 2009 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Sell | S | 4.96 | 100 | 496 | 71,957 | 72.1 K to 72 K (-0.14 %) |
Aug 03 2009 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Sell | S | 5.00 | 100 | 500 | 72,057 | 72.2 K to 72.1 K (-0.14 %) |
Aug 03 2009 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Sell | S | 5.01 | 100 | 501 | 72,157 | 72.3 K to 72.2 K (-0.14 %) |
Jul 02 2009 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Sell | S | 5.53 | 100 | 553 | 72,257 | 72.4 K to 72.3 K (-0.14 %) |
Jul 02 2009 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Sell | S | 5.57 | 300 | 1,671 | 72,357 | 72.7 K to 72.4 K (-0.41 %) |
Jul 02 2009 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Sell | S | 5.58 | 200 | 1,116 | 72,657 | 72.9 K to 72.7 K (-0.27 %) |
Jul 02 2009 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Sell | S | 5.59 | 100 | 559 | 72,857 | 73 K to 72.9 K (-0.14 %) |
Jul 02 2009 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Sell | S | 5.62 | 100 | 562 | 72,957 | 73.1 K to 73 K (-0.14 %) |
Jul 02 2009 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Sell | S | 5.63 | 200 | 1,126 | 73,057 | 73.3 K to 73.1 K (-0.27 %) |
Jul 02 2009 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Sell | S | 5.65 | 800 | 4,520 | 73,257 | 74.1 K to 73.3 K (-1.08 %) |
Jul 02 2009 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Sell | S | 5.67 | 200 | 1,134 | 74,057 | 74.3 K to 74.1 K (-0.27 %) |
Jun 16 2009 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Sell | S | 4.94 | 500 | 2,470 | 74,257 | 74.8 K to 74.3 K (-0.67 %) |
Jun 16 2009 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Sell | S | 4.97 | 2,625 | 13,046 | 74,757 | 77.4 K to 74.8 K (-3.39 %) |
Jun 16 2009 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Sell | S | 4.98 | 1,400 | 6,972 | 77,382 | 78.8 K to 77.4 K (-1.78 %) |
Jun 16 2009 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Sell | S | 4.99 | 200 | 998 | 78,782 | 79 K to 78.8 K (-0.25 %) |
Jun 16 2009 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Sell | S | 5.00 | 500 | 2,500 | 78,982 | 79.5 K to 79 K (-0.63 %) |
Jun 16 2009 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Sell | S | 5.01 | 400 | 2,004 | 79,482 | 79.9 K to 79.5 K (-0.50 %) |
Jun 16 2009 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Sell | S | 5.07 | 300 | 1,521 | 79,882 | 80.2 K to 79.9 K (-0.37 %) |
Jun 16 2009 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Sell | S | 5.15 | 100 | 515 | 80,182 | 80.3 K to 80.2 K (-0.12 %) |
Jun 16 2009 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Sell | S | 5.16 | 100 | 516 | 80,282 | 80.4 K to 80.3 K (-0.12 %) |
Jun 09 2009 | ISPH | INSPIRE PHARMACEUT ... | LEFF JONATHAN S | Director | Option Exercise | A | 5.05 | 30,000 | 151,500 | 30,000 | |
Jun 09 2009 | ISPH | INSPIRE PHARMACEUT ... | Kent Richard S | Director | Option Exercise | A | 5.05 | 30,000 | 151,500 | 30,000 | |
Jun 09 2009 | ISPH | INSPIRE PHARMACEUT ... | HOLMER ALAN F | Director | Option Exercise | A | 5.05 | 30,000 | 151,500 | 30,000 | |
Jun 09 2009 | ISPH | INSPIRE PHARMACEUT ... | Hutson Nancy J | Director | Option Exercise | A | 5.05 | 30,000 | 151,500 | 30,000 | |
Jun 09 2009 | ISPH | INSPIRE PHARMACEUT ... | FREY KIP | Director | Option Exercise | A | 5.05 | 30,000 | 151,500 | 30,000 | |
May 18 2009 | ISPH | INSPIRE PHARMACEUT ... | SCHACHLE JOSEPH K | EVP, Chief Commerci ... | Option Exercise | A | 3.84 | 10,000 | 38,400 | 10,000 | |
May 18 2009 | ISPH | INSPIRE PHARMACEUT ... | SHAFFER CHRISTY L | President & CEO | Option Exercise | A | 3.84 | 29,500 | 113,280 | 29,500 | |
Jun 09 2009 | ISPH | INSPIRE PHARMACEUT ... | LEE KENNETH B JR | Director | Option Exercise | A | 5.05 | 10,000 | 50,500 | 10,000 | |
Jun 09 2009 | ISPH | INSPIRE PHARMACEUT ... | LEE KENNETH B JR | Director | Option Exercise | A | 5.05 | 30,000 | 151,500 | 30,000 | |
May 18 2009 | ISPH | INSPIRE PHARMACEUT ... | Brazzell Romulus K | EVP & Head, Ophthal ... | Option Exercise | A | 3.84 | 13,250 | 50,880 | 13,250 | |
May 18 2009 | ISPH | INSPIRE PHARMACEUT ... | STAAB THOMAS R II | CFO & Treasurer | Option Exercise | A | 3.84 | 13,250 | 50,880 | 13,250 | |
May 18 2009 | ISPH | INSPIRE PHARMACEUT ... | Spagnardi Joseph M | Senior VP, GC & Sec ... | Option Exercise | A | 3.84 | 10,250 | 39,360 | 10,250 | |
May 18 2009 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Option Exercise | A | 3.84 | 12,000 | 46,080 | 12,000 | |
Mar 20 2009 | ISPH | INSPIRE PHARMACEUT ... | SCHACHLE JOSEPH K | EVP, Chief Commerci ... | Option Exercise | A | 3.79 | 10,000 | 37,900 | 10,000 | |
Mar 20 2009 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Option Exercise | A | 3.79 | 12,000 | 45,480 | 12,000 | |
Mar 20 2009 | ISPH | INSPIRE PHARMACEUT ... | STAAB THOMAS R II | CFO & Treasurer | Option Exercise | A | 3.79 | 13,250 | 50,218 | 13,250 | |
Mar 20 2009 | ISPH | INSPIRE PHARMACEUT ... | Spagnardi Joseph M | Senior VP, GC & Sec ... | Option Exercise | A | 3.79 | 10,250 | 38,848 | 10,250 | |
Mar 20 2009 | ISPH | INSPIRE PHARMACEUT ... | Brazzell Romulus K | EVP & Head, Ophthal ... | Option Exercise | A | 3.79 | 13,250 | 50,218 | 13,250 | |
Mar 20 2009 | ISPH | INSPIRE PHARMACEUT ... | SHAFFER CHRISTY L | President & CEO | Option Exercise | A | 3.79 | 29,500 | 111,805 | 29,500 | |
Feb 10 2009 | ISPH | INSPIRE PHARMACEUT ... | HOLMER ALAN F | Director | Option Exercise | A | 3.85 | 7,500 | 28,875 | 7,500 | |
Nov 06 2008 | ISPH | INSPIRE PHARMACEUT ... | LEE KENNETH B JR | Director | Buy | P | 3.88 | 1,600 | 6,208 | 2,400 | 800 to 2.4 K (+200.00 %) |
Nov 06 2008 | ISPH | INSPIRE PHARMACEUT ... | LEE KENNETH B JR | Director | Buy | P | 3.88 | 400 | 1,551 | 800 | 400 to 800 (+100.00 %) |
Nov 12 2008 | ISPH | INSPIRE PHARMACEUT ... | FREY KIP | Director | Buy | P | 3.40 | 2,000 | 6,800 | 2,000 | 0 to 2 K |
Nov 06 2008 | ISPH | INSPIRE PHARMACEUT ... | SHAFFER CHRISTY L | President & CEO | Option Exercise | A | 3.78 | 29,500 | 111,510 | 29,500 | |
Nov 06 2008 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Option Exercise | M | 0.42 | 9,131 | 3,835 | 0 | |
Nov 06 2008 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Option Exercise | A | 3.78 | 13,250 | 50,085 | 13,250 | |
Nov 06 2008 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | EVP & Chf, Research ... | Buy | M | 0.42 | 9,131 | 3,835 | 80,382 | 71.3 K to 80.4 K (+12.82 %) |
Nov 06 2008 | ISPH | INSPIRE PHARMACEUT ... | SCHACHLE JOSEPH K | EVP, Chief Commerci ... | Option Exercise | A | 3.78 | 13,250 | 50,085 | 13,250 | |
Nov 06 2008 | ISPH | INSPIRE PHARMACEUT ... | STAAB THOMAS R II | CFO & Treasurer | Option Exercise | A | 3.78 | 13,250 | 50,085 | 13,250 | |
Nov 06 2008 | ISPH | INSPIRE PHARMACEUT ... | Brazzell Romulus K | Sr. VP, Ophthalmic ... | Option Exercise | A | 3.78 | 10,250 | 38,745 | 10,250 | |
Nov 06 2008 | ISPH | INSPIRE PHARMACEUT ... | Spagnardi Joseph M | Senior VP, GC & Sec ... | Option Exercise | A | 3.78 | 10,250 | 38,745 | 10,250 | |
Aug 18 2008 | ISPH | INSPIRE PHARMACEUT ... | SHAFFER CHRISTY L | President & CEO | Option Exercise | A | 4.44 | 29,500 | 130,980 | 29,500 | |
Aug 18 2008 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | Chf Sci Off & EVP S ... | Option Exercise | A | 4.44 | 13,250 | 58,830 | 13,250 | |
Aug 18 2008 | ISPH | INSPIRE PHARMACEUT ... | SCHACHLE JOSEPH K | EVP, Chief Commerci ... | Option Exercise | A | 4.44 | 13,250 | 58,830 | 13,250 | |
Aug 18 2008 | ISPH | INSPIRE PHARMACEUT ... | STAAB THOMAS R II | CFO & Treasurer | Option Exercise | A | 4.44 | 13,250 | 58,830 | 13,250 | |
Aug 18 2008 | ISPH | INSPIRE PHARMACEUT ... | Brazzell Romulus K | Sr. VP, Ophthalmic ... | Option Exercise | A | 4.44 | 10,250 | 45,510 | 10,250 | |
Aug 18 2008 | ISPH | INSPIRE PHARMACEUT ... | Spagnardi Joseph M | Senior VP, GC & Sec ... | Option Exercise | A | 4.44 | 10,250 | 45,510 | 10,250 | |
Jul 23 2008 | ISPH | INSPIRE PHARMACEUT ... | KELLERMAN DONALD J | Senior VP, Developm ... | Sell | D | 0.00 | 12,000 | 0 | 8,000 | 20 K to 8 K (-60.00 %) |
Jun 12 2008 | ISPH | INSPIRE PHARMACEUT ... | LEFF JONATHAN S | Director | Option Exercise | A | 5.00 | 30,000 | 150,000 | 30,000 | |
Jun 12 2008 | ISPH | INSPIRE PHARMACEUT ... | Hutson Nancy J | Director | Option Exercise | A | 5.00 | 30,000 | 150,000 | 30,000 | |
Jun 12 2008 | ISPH | INSPIRE PHARMACEUT ... | FREY KIP | Director | Option Exercise | A | 5.00 | 30,000 | 150,000 | 30,000 | |
Jun 12 2008 | ISPH | INSPIRE PHARMACEUT ... | Kent Richard S | Director | Option Exercise | A | 5.00 | 30,000 | 150,000 | 30,000 | |
Jun 12 2008 | ISPH | INSPIRE PHARMACEUT ... | LEE KENNETH B JR | Director | Option Exercise | A | 5.00 | 10,000 | 50,000 | 10,000 | |
Jun 12 2008 | ISPH | INSPIRE PHARMACEUT ... | LEE KENNETH B JR | Director | Option Exercise | A | 5.00 | 30,000 | 150,000 | 30,000 | |
May 19 2008 | ISPH | INSPIRE PHARMACEUT ... | YERXA BENJAMIN R | Chf Sci Off & EVP S ... | Option Exercise | A | 3.49 | 14,000 | 48,860 | 14,000 | |
May 19 2008 | ISPH | INSPIRE PHARMACEUT ... | SHAFFER CHRISTY L | President & CEO | Option Exercise | A | 3.49 | 29,500 | 102,955 | 29,500 |